Rh2 Synergistically Enhances Paclitaxel or Mitoxantrone in Prostate Cancer Models
Abstract
Purpose:
We explored the efficacy of the ginsenoside Rh2 and examined its impact on the effective dose of paclitaxel and mitoxantrone in the LNCaP prostate tumor model.
Materials and Methods:
Cultured LNCaP cell viability was assessed following treatment (48 hours) with Rh2 (0 to 40 μM) alone or in combination with paclitaxel and mitoxantrone. Synergism or antagonism observed when combining treatment was calculated using CalcuSyn software (Biosoft®). In addition, the inhibition of LNCaP human xenograft tumor growth was examined in vivo when Rh2 treatment was combined with chemotherapy. Harvested tumors were immunohistochemical stained with p27kip and Ki67.
Results:
Rh2 and paclitaxel act synergistically in cultured LNCaP cells to lower ED50 and ED75 values. Rh2 and mitoxantrone are also synergistic. However, when combined as ED95, an antagonistic effect was observed in this cell line. Treatment of LNCaP tumors by Rh2 plus paclitaxel produced a significant decrease in tumor growth and serum prostate specific antigen. Immunohistochemical analysis revealed an apparent but nonsignificant effect on proliferation markers in LNCaP tumors. When Rh2 and mitoxantrone were combined in vivo, there was no significant benefit observed.
Conclusions:
These results indicate that the combination of Rh2 and paclitaxel has an effect on growth inhibition that is greater and synergistic, as demonstrated in a cultured LNCaP cell line. Conversely combining Rh2 with mitoxantrone appears to elicit no benefit. Therefore, combination therapy using chemotherapy and Rh2 requires further investigation.
References
- 1 : Brief introduction of Panax ginseng. J Korean Med Sci2001; 16: S3. Google Scholar
- 2 : Effects of ginsenosides Rg3 and Rh2 on the proliferation of prostate cancer cells. Arch Pharmacol Res2004; 27: 429. Google Scholar
- 3 : Apoptotic effects of ginsenoside Rh2 on human malignant melanoma A375-S2 cells. Acta Pharmacol Sin2002; 23: 315. Google Scholar
- 4 : Ginsenoside-Rh2 blocks the cell cycle of SK-HEP-1 cells at the G1/S boundary by selectively inducing the protein expression of p27kip1. Cancer Lett1996; 110: 193. Google Scholar
- 5 : Inhibitory effects of ginsenoside Rh2 on tumor growth in nude mice bearing human ovarian cancer cells. Jpn J Cancer Res1998; 89: 733. Google Scholar
- 6 : Inhibition of human ovarian cancer cell proliferation in vitro by ginsenoside Rh2 and adjuvant effects to cisplatin in vivo. Anticancer Drugs1991; 2: 63. Google Scholar
- 7 : Rh2, a compound extracted from ginseng, hypersensitizes multidrug-resistant tumor cells to chemotherapy. Can J Physiol Pharmacol2004; 82: 431. Google Scholar
- 8 Guns, E. S., Xie, X., Madera, C., Jia, W. and Goldenberg, L.: Chemosensitization of paclitaxel by ginsenoside Rh2: LNCaP tumor growth suppression in vivo. Presented at meeting of Western Section, American Urological Association, San Diego, California, August 20–27, 2004 Google Scholar
- 9 : Paclitaxel in the treatment of hormone-refractory prostate cancer. Semin Oncol1999; 26: 109. Google Scholar
- 10 : Chemotherapy for patients with advanced prostate carcinoma: a new option for therapy. Cancer2000; 88: 3015. Google Scholar
- 11 : Cytotoxicity test with simplified crystal violet staining method using microtitre plates and its application to injection drugs. Toxicol Vitro1989; 3: 317. Google Scholar
- 12 : Quantitative analysis of dose effect relationships: the combined effects of multiple drugs or enzyme inhibitors. Adv Enzyme Regul1984; 22: 27. Google Scholar
- 13 : Serum prostate specific antigen levels in mice bearing human prostate LNCaP tumors are determined by tumor volume and endocrine and growth factors. Cancer Res1992; 52: 1598. Google Scholar
- 14 : Acceleration of human prostate cancer growth in vivo by factors produced by prostate and bone fibroblasts. Cancer Res1991; 51: 3753. Google Scholar
- 15 : Standardization and reproducibility in diagnostic immunohistochemistry. Hum Pathol1994; 25: 1107. Google Scholar
- 16 : Mechanistic studies on protopanaxadiol, Rh2, and ginseng (Panax quinquefolius) extract induced cytotoxicity in intestinal Caco-2 cells. J Biochem Mol Toxicol2004; 18: 143. Google Scholar
- 17 : Generalized equations for the analysis of inhibitions of Michaelis-Menten and higher-order kinetic systems with two or more mutually exclusive and nonexclusive inhibitors. Eur J Biochem1981; 115: 207. Google Scholar
- 18 : G1 phase-specific suppression of the Cdk2 activity by ginsenoside Rh2 in cultured murine cells. Life Sci1997; 60: 39. Google Scholar
- 19 : American ginseng and breast cancer therapeutic agents synergistically inhibit MCF-7 breast cancer cell growth. J Surg Oncol1999; 72: 230. Google Scholar
- 20 : Ginsenosides 20(S)-protopanaxadiol and Rh2 reduce cell proliferation and increase sub-G1 cells in two cultured intestinal cell lines, Int-407 and Caco-2. Can J Physiol Pharmacol2004; 82: 183. Google Scholar
